Exploring the mechanism of Artemisia argyi chemical composition for ulcerative colitis based on network pharmacology

•Twenty-five compounds were isolated from Artemisia argyi, and ETP showed strong anti-inflammatory ability.•This was the first report on the biological activity of ETP and the first to elucidate the potential mechanism of ETP in the treatment of ulcerative colitis through network pharmacology.•ETP m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arabian journal of chemistry 2023-09, Vol.16 (9), p.105050, Article 105050
Hauptverfasser: Li, Menghe, Liu, Jianghao, La, Caiwenjie, Liu, Tao, Zhao, Zibo, Wang, Zui, Dai, Minghui, Chen, Jiming, Ren, Zhe, Ye, Cuifang, Wang, Yifei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Twenty-five compounds were isolated from Artemisia argyi, and ETP showed strong anti-inflammatory ability.•This was the first report on the biological activity of ETP and the first to elucidate the potential mechanism of ETP in the treatment of ulcerative colitis through network pharmacology.•ETP may target MMP1, MMP9, MUC1, S1PR1, and MMP12 to treat ulcerative colitis. A persistent digestive disorder known as ulcerative colitis (UC) is characterized by a high rate of recurrence and a difficult road to full recovery. An herbal treatment with a long history of use in conventional Chinese medicine, Artemisia argyi, has shown encouraging results in preventing the return of clinical UC. We carried out an experiment to isolate and identify the small molecules in Artemisia argyi to investigate the chemical makeup of the therapeutic UC in this plant. Following an activity screen, we discovered that 3β-ethoxytanapartholide (ETP) had significantly greater anti-inflammatory action than the medicine we had chosen as a positive control, dexamethasone, and this is the first report of ETP in terms of biological activity. Systematic network pharmacological analysis confirmed that ETP acted on multiple targets during the pathogenesis of UC. These targets regulate a variety of UC-related signaling pathways, including but not limited to TNF, IL-17, and Ca2+ signaling. Molecular dynamics simulations and MM-PBSA results showed that ETP was able to form stable complexes with five targets, MMP1, MMP9, MUC1, S1PR1 and MMP12. The current work has previously shown the unknown anti-inflammatory ability of ETP and discovered that ETP can modulate various pathways throughout the development of UC to produce therapeutic advantages. These ground-breaking results highlight the urgent need for more analysis and development of ETP as a potential treatment plan for UC.
ISSN:1878-5352
1878-5379
DOI:10.1016/j.arabjc.2023.105050